|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4035 | |
| A61K 31/437 | |||
| A61K 31/495 | |||
| A61K 31/496 | |||
| A61P 7/00 |
| (11) | Number of the document | 3137073 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15717916.9 |
| Date of filing the European patent application | 2015-04-27 | |
| (97) | Date of publication of the European application | 2017-03-08 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/059037 |
| Date | 2015-04-27 |
| (87) | Number | WO 2015/165842 |
| Date | 2015-11-05 |
| (30) | Number | Date | Country code |
| 14166497 | 2014-04-30 | EP |
| (72) |
ALBERATI, Daniela, CH
KOERNER, Annette, DE
PINARD, Emmanuel, FR
WINTER, Michael, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | GLYT1 INHIBITORS FOR USE IN THE TREATMENT OF HEMATOLOGICAL DISORDERS |
| GLYT1 INHIBITORS FOR USE IN THE TREATMENT OF HEMATOLOGICAL DISORDERS |